Is Pasithea Therapeutics Corp. Warrant (KTTAW) undervalued?
Pasithea Therapeutics Corp. Warrant (KTTAW) is a biotechnology company listed on US.
This page asks whether Pasithea Therapeutics Corp. Warrant (KTTAW) looks cheap on cached numbers — not a DCF toy and not a buy alert.
Without a cached income statement, “undervalued KTTAW” is a slogan. Wait for the print.
KTTAW currently screens at market cap $0. Cheap versus history or peers still needs a filing reason; a low multiple can be a value trap.
A new KTTAW 10-Q can flip this screen overnight. The SEC page is the source.
Not investment advice. Compare KTTAW to the stock page model before you treat a low multiple as a gift.
Not investment advice.